Kevin Henry has resigned as group finance director of Airea. He will leave the flooring company on 28 August 2009. A successor has yet to be appointed but in the short term, Roger Salt has added the role of company secretary to his existing duties as finance director – operations.Geoffrey Smith has resigned as finance director of Fulcrum Pharma. He will leave the company on 30 June 2009. Barry Knight has been appointed chief financial officer and as a director of Fulcrum Pharma in succession to Smith. Knight was most recently finance and administration director of KeyMed and CFO of Trigen and Trigen Holdings. Bradford & Bingley has confirmed that its group finance director, Chris Willford, will step down on 30 June 2009.Allan Watson has been appointed chief financial officer of pharmaceutical company ProStrakan. He replaces Paul Garvey. Watson joins the firm from medical technology company Optos, where he has been CFO since 2003. Picture source
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.